Literature DB >> 18996106

A case of hook effect in the serum free light chain assay using the Olympus AU400e.

Christopher R McCudden1, Peter M Voorhees, Catherine A Hammett-Stabler.   

Abstract

We describe a case where a woman with an IgG lambda monoclonal gammopathy had an undetectable serum free lambda light chain due to antigen excess. The patient had a three year history of multiple myeloma and initially presented with an elevated serum free lambda light chain. The serum free lambda light chain concentration increased over the course of several months to >4000 mg/L (reference interval 5.7-26.3 mg/L) and then suddenly dropped to <3.0 mg/L. Paradoxically, during this time the monoclonal IgG lambda concentration measured using serum protein electrophoresis increased from 44 to 59 g/dL. Serial dilution of the patient's serum specimen revealed that the serum free lambda light chain was actually 3130 mg/L. This case represents an example of antigen excess or 'hook effect' using the serum free light chain assay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996106     DOI: 10.1016/j.clinbiochem.2008.10.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Quantitative analysis of therapeutic drugs in dried blood spot samples by paper spray mass spectrometry: an avenue to therapeutic drug monitoring.

Authors:  Nicholas Edward Manicke; Paul Abu-Rabie; Neil Spooner; Zheng Ouyang; R Graham Cooks
Journal:  J Am Soc Mass Spectrom       Date:  2011-06-21       Impact factor: 3.109

Review 2.  Considerations for Group Testing: A Practical Approach for the Clinical Laboratory.

Authors:  Jun G Tan; Aznan Omar; Wendy By Lee; Moh S Wong
Journal:  Clin Biochem Rev       Date:  2020-12

3.  Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma.

Authors:  S H K Murng; L Follows; P Whitfield; J A Snowden; K Swallow; K Green; R Sargur; W Egner
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

Review 4.  The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry.

Authors:  Andrew N Hoofnagle; Mark H Wener
Journal:  J Immunol Methods       Date:  2009-06-16       Impact factor: 2.303

5.  The analytical performance evaluation of Freelite™ Human Kappa Free and Human Lambda Free on the SPAPLUS™ immunoturbidimetric analyzer.

Authors:  Kyong-Ho Cha; Yang Bo Sim; Hyojin Chae; Hae-il Park; Myungshin Kim; Yonggoo Kim
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

6.  Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate.

Authors:  Lilie L Lin; Rosemarie Mick; Jeffrey Ware; James Metz; Robert Lustig; Neha Vapiwala; Ramesh Rengan; Ann R Kennedy
Journal:  Oncol Lett       Date:  2014-02-05       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.